Marvion Inc. has entered into a Stock Purchase Agreement with Mak Pak Fai Ray, where the investor will purchase $200,000 of the Company's common stock at a price of $0.0268 per share. This agreement was finalized on December 16, 2025. The filing includes detailed representations and warranties from both Marvion Inc. an...

Medalist Diversified REIT, Inc. declared a quarterly dividend of $0.0675 per share on its common stock, payable in cash on January 13, 2026, to shareholders of record as of January 8, 2026. Additionally, the Board of Directors granted waivers of ownership limitations to CEO Frank Kavanaugh and CFO C. Brent Winn, Jr. Th...

Dina Powell McCormick has resigned from her position as a member of the Board of Directors at Meta Platforms, Inc., effective immediately. The resignation was reported on December 19, 2025. No further details regarding the reasons for her departure were provided in the filing....

MetaVia Inc. has regained compliance with the Nasdaq Capital Market's Minimum Bid Price Requirement. The company initially received a notice on May 29, 2025, for failing to meet the $1.00 minimum bid price for 30 consecutive trading days. MetaVia was granted a 180-day extension until May 26, 2026, to regain compliance....

This Form 8-K reports the retirement of Donald J. Spring, Chief Accounting Officer & Corporate Controller of Midland States Bank and principal accounting officer of Midland States Bancorp, Inc., effective January 2, 2026. Eric T. Lemke, the Company’s Chief Financial Officer, will assume the role of principal accounting...

Mirum Pharmaceuticals, Inc. has entered into a Subscription Agreement with entities associated with TCG Crossover Management, LLC for a private placement. The agreement involves the purchase of 1,000,000 shares of the Company's common stock for approximately $68,480,000, at a price of $68.48 per share. This private pla...

Mirum Pharmaceuticals, Inc. has announced that it received Paragraph IV Certification Notice Letters from Sandoz, Inc., Annora Pharma Private Limited, Zydus Lifesciences Global FZE, and Zenara Pharma Private Limited. These companies have submitted Abbreviated New Drug Applications (ANDAs) to the FDA seeking approval fo...

The Annual Meeting of Stockholders of Monroe Federal Bancorp, Inc. was held on December 17, 2025. The stockholders elected Julie M. Broerman Daniels, Lewis R. Renollet, and Sarah G. Worley as directors for three-year terms. The Monroe Federal Bancorp, Inc. 2025 Equity Incentive Plan was approved. The appointment of Wip...

On December 15, 2025, My Size, Inc. (the “Company”) approved grants of restricted stock awards (RS Awards) to its executive officers under the Company’s 2017 Equity Incentive Plan. These awards include performance-based RS Awards contingent on achieving specific profit and business targets, and time-based RS Awards tha...

National Health Investors, Inc. has entered into new Change in Control Severance Agreements (CIC Severance Agreements) with five named executive officers: D. Eric Mendelsohn, Kristin S. Gaines, Kevin C. Pascoe, John L. Spaid, and David L. Travis. These agreements, effective December 15, 2025, replace previous versions ...

NCR Atleos Corporation announced on December 17, 2025, that its Compensation and Human Resource Committee approved new restrictive covenant agreements for senior executives, including the CEO, CFO, COO, and General Counsel. These agreements extend the non-competition period to 24 months post-employment to protect the c...

This filing details News Corporation's ongoing stock repurchase programs. The company is authorized to acquire up to an aggregate of $1 billion in Class A and Class B common stock under its 2021 Repurchase Program and an additional $1 billion under its 2025 Repurchase Program. Daily disclosures are provided to the Aust...

Union Pacific Corporation and Norfolk Southern Corporation have jointly filed an application with the Surface Transportation Board (STB) to approve their proposed merger. This combination aims to create the first transcontinental railroad in the United States, spanning approximately 7,000 miles and connecting 43 states...

Northern Technologies International Corporation ("NTIC") and JPMorgan Chase Bank, N.A. ("JPM") entered into a Note Modification Agreement on December 18, 2025. This agreement modifies a Line of Credit Note originally dated July 8, 2025, with a principal amount of $10.0 million. The modification extends the maturity dat...

Nauticus Robotics, Inc. reported on December 16, 2025, that its Chief Technical Officer, John D. Yamokoski, intends to resign to pursue another opportunity. Mr. Yamokoski will continue in his role until January 2, 2026. The company is based in Delaware and its principal executive offices are located at 17146 Feathercra...

New Fortress Energy Inc. (the Company) entered into a Term Loan B Forbearance Agreement on December 17, 2025, with certain lenders after failing to make required interest and principal payments. This agreement allows lenders to forbear from accelerating payments until January 9, 2026, at which point the Company's entir...

NextCure, Inc. has entered into an at-the-market offering agreement with H.C. Wainwright & Co., LLC, allowing the company to sell up to $14.5 million of its common stock. Sales will occur from time to time based on market conditions and the company's capital needs. The stock will be sold under a prospectus supplement f...

ONE Gas, Inc. announced on December 19, 2025, that it has increased its commercial paper program. Effective December 17, 2025, the aggregate principal amount of commercial paper notes that may be outstanding at any time has been raised to $1.50 billion from the previous limit of $1.35 billion. All other terms and condi...

Optical Cable Corporation (OCC) reported its financial results for the fourth quarter and fiscal year 2025, ending October 31, 2025. For the full fiscal year 2025, OCC saw a 9.5% increase in net sales to $73.0 million, compared to $66.7 million in fiscal year 2024. Gross profit rose by 24.1% to $22.6 million, with a gr...

Okta, Inc. announced on December 18, 2025, the expansion of its Board of Directors from 10 to 11 members with the appointment of Rob Bernshteyn and Paul Sagan as independent directors, effective December 19, 2025. Mr. Bernshteyn joins as a Class II director until the 2028 Annual Meeting of Stockholders and will serve o...

On December 17, 2025, Opus Genetics, Inc. announced that its global commercialization partner, Viatris Inc., filed a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) for Phentolamine Ophthalmic Solution 0.75% (Phentolamine) for the treatment of presbyopia. This filing is support...

Ouster, Inc. has filed a Form 8-K to report the fourth amendment to its NNN Lease Agreement for its headquarters in San Francisco, California. The amendment, entered into on December 17, 2025, extends the lease term to August 31, 2034. Effective January 1, 2026, the annual base rent will decrease to $50.00 per rental s...

Outlook Therapeutics, Inc. announced its financial results for the fourth fiscal quarter and the full fiscal year ended September 30, 2025. The company reported a net loss attributable to common stockholders of $62.4 million, or $1.79 per basic and diluted share, for fiscal year 2025, compared to a net loss of $75.4 mi...

Par Pacific Holdings, Inc. (Par Pacific) has entered into Amendment No. 3 to its Term Loan Credit Agreement. This amendment, effective December 17, 2025, reduces the Applicable Margin by 50 basis points, resulting in new interest rates. Base rate loans will now bear interest at the applicable base rate plus 2.25%, and ...

Paychex, Inc. reported strong financial results for the second quarter of fiscal 2026, ended November 30, 2025. Total revenue increased by 18% year-over-year to $1.6 billion, driven by a 21% increase in Management Solutions revenue, which was bolstered by the acquisition of Paycor HCM, Inc. PEO and Insurance Solutions ...